Contact
searchSearch
HMP Global

Opioid Use Disorder Topic Center

Featured Article

News
OUD Treatment Inequities Identified for Medicaid Beneficiaries With Disabilities
03/16/2023
Maria Asimopoulos
Researchers compared opioid use disorder treatment trends among Medicaid members with vs without physical, sensory, developmental, and cognitive disabilities.
Researchers compared opioid use disorder treatment trends among Medicaid members with vs without physical, sensory, developmental, and cognitive disabilities.
Researchers compared opioid use...
03/16/2023
First Report Managed Care
News
OOP Costs for Buprenorphine Down, But Could Still Present a Barrier for Some
03/06/2023
Jolynn Tumolo
Average daily out-of-pocket costs for buprenorphine prescriptions decreased between 2015 and 2020, but trends varied by payer type and remained high for some patients, according to a research team from the Centers for Disease Control and...
Average daily out-of-pocket costs for buprenorphine prescriptions decreased between 2015 and 2020, but trends varied by payer type and remained high for some patients, according to a research team from the Centers for Disease Control and...
Average daily out-of-pocket...
03/06/2023
First Report Managed Care
News
New York Providers Now Required to Prescribe Naloxone to Some Patients on Opioid Painkillers
01/05/2023
Michelle Andrews
The law is intended to bolster the number of naloxone prescriptions and reduce stigma-related barriers for patients who take opioids.
The law is intended to bolster the number of naloxone prescriptions and reduce stigma-related barriers for patients who take opioids.
The law is intended to bolster...
01/05/2023
Pharmacy Learning Network
From Pharmacy Learning Network
News
Addiction Clinic Offering Financial Reward Program Met With Alleged Medicaid Fraud Inquiry
12/20/2022
Katheryn Houghton
The outpatient addiction clinic planned to offer gift cards and vouchers to people with substance use disorders as a form of contingency management.
The outpatient addiction clinic planned to offer gift cards and vouchers to people with substance use disorders as a form of contingency management.
The outpatient addiction clinic...
12/20/2022
First Report Managed Care
News
In Rural America, Deadly Costs of Opioids Outweigh the Dollars Tagged to Address Them
12/12/2022
Aneri Pattani; Rae Ellen Bichell
Some experts say settlement funds intended to bolster health services for people with opioid use disorder are not being distributed in sufficient sums to rural areas.
Some experts say settlement funds intended to bolster health services for people with opioid use disorder are not being distributed in sufficient sums to rural areas.
Some experts say settlement...
12/12/2022
First Report Managed Care
News
Addiction Treatment Proponents Urge Rural Clinicians to Pitch In by Prescribing Medication
12/01/2022
Tony Leys
Front-line health care professionals are being encouraged by federal and state authorities to prescribe medications containing buprenorphine to patients with opioid use disorder.
Front-line health care professionals are being encouraged by federal and state authorities to prescribe medications containing buprenorphine to patients with opioid use disorder.
Front-line health care...
12/01/2022
First Report Managed Care
Headshot of Andrea Ruskin, VA Connecticut Healthcare System
Conference Coverage
The Future of Chronic Pain Management in Patients With Cancer
09/19/2022
Maria Asimopoulos
Andrea Ruskin, MD, offers insight into her session at the 2022 AVAHO Annual Meeting in which she discussed the use of comprehensive assessments to address chronic pain in patients treated for cancer.
Andrea Ruskin, MD, offers insight into her session at the 2022 AVAHO Annual Meeting in which she discussed the use of comprehensive assessments to address chronic pain in patients treated for cancer.
Andrea Ruskin, MD, offers...
09/19/2022
First Report Managed Care
News
HHS Announces $1.5 Billion Funding Opportunity for State Opioid Response Grant Program
05/20/2022
Samantha Matthews
The US Department of Health and Human Services recently announced a State Opioid Response grant funding opportunity that will provide nearly $1.5 billion to states and territories.
The US Department of Health and Human Services recently announced a State Opioid Response grant funding opportunity that will provide nearly $1.5 billion to states and territories.
The US Department of Health and...
05/20/2022
First Report Managed Care
News
Digital Therapeutic Cost-Effective as Adjunct to Buprenorphine for Patients With OUD
04/07/2022
Maria Asimopoulos
When used as adjunctive therapy with outpatient buprenorphine, a prescription digital therapeutic was cost-effective at a $50,000 willingness-to-pay threshold, researchers concluded.
When used as adjunctive therapy with outpatient buprenorphine, a prescription digital therapeutic was cost-effective at a $50,000 willingness-to-pay threshold, researchers concluded.
When used as adjunctive therapy...
04/07/2022
First Report Managed Care
News
Methadone vs Buprenorphine for Reduced Overdose Risk, Treatment Retention
03/08/2022
Maria Asimopoulos
Researchers found treatment with methadone or buprenorphine resulted in different overdose and retention outcomes among patients with opioid use disorder.
Researchers found treatment with methadone or buprenorphine resulted in different overdose and retention outcomes among patients with opioid use disorder.
Researchers found treatment with...
03/08/2022
Pharmacy Learning Network
From Pharmacy Learning Network
News
Digital Therapeutic for Opioid Use Disorder Cuts Medical Costs
07/26/2021
Jolynn Tumolo
A prescription digital therapeutic for the delivery of neurobehavioral therapy to patients with opioid use disorder treated with buprenorphine reduced hospital-based medical costs by more than $2000 per engaged patient, according to recent...
A prescription digital therapeutic for the delivery of neurobehavioral therapy to patients with opioid use disorder treated with buprenorphine reduced hospital-based medical costs by more than $2000 per engaged patient, according to recent...
A prescription digital...
07/26/2021
First Report Managed Care

Newsfeed

News
OUD Treatment Inequities Identified for Medicaid Beneficiaries With Disabilities
03/16/2023
Maria Asimopoulos
Researchers compared opioid use disorder treatment trends among Medicaid members with vs without physical, sensory, developmental, and cognitive disabilities.
Researchers compared opioid use disorder treatment trends among Medicaid members with vs without physical, sensory, developmental, and cognitive disabilities.
Researchers compared opioid use...
03/16/2023
First Report Managed Care
News
OOP Costs for Buprenorphine Down, But Could Still Present a Barrier for Some
03/06/2023
Jolynn Tumolo
Average daily out-of-pocket costs for buprenorphine prescriptions decreased between 2015 and 2020, but trends varied by payer type and remained high for some patients, according to a research team from the Centers for Disease Control and...
Average daily out-of-pocket costs for buprenorphine prescriptions decreased between 2015 and 2020, but trends varied by payer type and remained high for some patients, according to a research team from the Centers for Disease Control and...
Average daily out-of-pocket...
03/06/2023
First Report Managed Care
News
New York Providers Now Required to Prescribe Naloxone to Some Patients on Opioid Painkillers
01/05/2023
Michelle Andrews
The law is intended to bolster the number of naloxone prescriptions and reduce stigma-related barriers for patients who take opioids.
The law is intended to bolster the number of naloxone prescriptions and reduce stigma-related barriers for patients who take opioids.
The law is intended to bolster...
01/05/2023
Pharmacy Learning Network
News
Addiction Clinic Offering Financial Reward Program Met With Alleged Medicaid Fraud Inquiry
12/20/2022
Katheryn Houghton
The outpatient addiction clinic planned to offer gift cards and vouchers to people with substance use disorders as a form of contingency management.
The outpatient addiction clinic planned to offer gift cards and vouchers to people with substance use disorders as a form of contingency management.
The outpatient addiction clinic...
12/20/2022
First Report Managed Care
News
In Rural America, Deadly Costs of Opioids Outweigh the Dollars Tagged to Address Them
12/12/2022
Aneri Pattani; Rae Ellen Bichell
Some experts say settlement funds intended to bolster health services for people with opioid use disorder are not being distributed in sufficient sums to rural areas.
Some experts say settlement funds intended to bolster health services for people with opioid use disorder are not being distributed in sufficient sums to rural areas.
Some experts say settlement...
12/12/2022
First Report Managed Care
News
Addiction Treatment Proponents Urge Rural Clinicians to Pitch In by Prescribing Medication
12/01/2022
Tony Leys
Front-line health care professionals are being encouraged by federal and state authorities to prescribe medications containing buprenorphine to patients with opioid use disorder.
Front-line health care professionals are being encouraged by federal and state authorities to prescribe medications containing buprenorphine to patients with opioid use disorder.
Front-line health care...
12/01/2022
First Report Managed Care
News
HHS Announces $1.5 Billion Funding Opportunity for State Opioid Response Grant Program
05/20/2022
Samantha Matthews
The US Department of Health and Human Services recently announced a State Opioid Response grant funding opportunity that will provide nearly $1.5 billion to states and territories.
The US Department of Health and Human Services recently announced a State Opioid Response grant funding opportunity that will provide nearly $1.5 billion to states and territories.
The US Department of Health and...
05/20/2022
First Report Managed Care
News
Digital Therapeutic Cost-Effective as Adjunct to Buprenorphine for Patients With OUD
04/07/2022
Maria Asimopoulos
When used as adjunctive therapy with outpatient buprenorphine, a prescription digital therapeutic was cost-effective at a $50,000 willingness-to-pay threshold, researchers concluded.
When used as adjunctive therapy with outpatient buprenorphine, a prescription digital therapeutic was cost-effective at a $50,000 willingness-to-pay threshold, researchers concluded.
When used as adjunctive therapy...
04/07/2022
First Report Managed Care
News
Methadone vs Buprenorphine for Reduced Overdose Risk, Treatment Retention
03/08/2022
Maria Asimopoulos
Researchers found treatment with methadone or buprenorphine resulted in different overdose and retention outcomes among patients with opioid use disorder.
Researchers found treatment with methadone or buprenorphine resulted in different overdose and retention outcomes among patients with opioid use disorder.
Researchers found treatment with...
03/08/2022
Pharmacy Learning Network
News
Digital Therapeutic for Opioid Use Disorder Cuts Medical Costs
07/26/2021
Jolynn Tumolo
A prescription digital therapeutic for the delivery of neurobehavioral therapy to patients with opioid use disorder treated with buprenorphine reduced hospital-based medical costs by more than $2000 per engaged patient, according to recent...
A prescription digital therapeutic for the delivery of neurobehavioral therapy to patients with opioid use disorder treated with buprenorphine reduced hospital-based medical costs by more than $2000 per engaged patient, according to recent...
A prescription digital...
07/26/2021
First Report Managed Care
News
Asciminib Shows Durable Frontline Benefit in Newly Diagnosed CML
05/20/2026
Hannah Musick
At 96 weeks, asciminib demonstrated higher major molecular response rates and fewer treatment discontinuations due to adverse events compared with imatinib and second-generation tyrosine kinase inhibitors in newly diagnosed chronic myeloid...
At 96 weeks, asciminib demonstrated higher major molecular response rates and fewer treatment discontinuations due to adverse events compared with imatinib and second-generation tyrosine kinase inhibitors in newly diagnosed chronic myeloid...
At 96 weeks, asciminib...
05/20/2026
First Report Managed Care
News
The Effect of Nephologist Affiliation on PD Utilization for Patients With ESKD
05/20/2026
Rebecca Amrick
A retrospective study found that physician-facility alignment influenced treatment for patients with end-stage kidney disease (ESKD) and had a higher likelihood of promoting home-based therapies such as peritoneal dialysis (PD).
A retrospective study found that physician-facility alignment influenced treatment for patients with end-stage kidney disease (ESKD) and had a higher likelihood of promoting home-based therapies such as peritoneal dialysis (PD).
A retrospective study found that...
05/20/2026
First Report Managed Care
News
Ponatinib Demonstrates Greater Clinical Benefit Than Imatinib but With Significantly Higher Care Costs
05/20/2026
Rebecca Amrick
The tyrosine kinase inhibitor (TKI) ponatinib has demonstrated moderately better patient outcomes than imatinib, but its higher costs may complicate treatment decision-making for patients, payers, and providers when it comes to managing...
The tyrosine kinase inhibitor (TKI) ponatinib has demonstrated moderately better patient outcomes than imatinib, but its higher costs may complicate treatment decision-making for patients, payers, and providers when it comes to managing...
The tyrosine kinase inhibitor...
05/20/2026
First Report Managed Care
News
Severe Alcohol-Associated Hepatitis Raises Health Care Costs Across Multiple Care Settings
05/18/2026
Rebecca Amrick
Immediate care for alcohol-associated hepatitis (AH) greatly raises health care costs across outpatient, emergency department (ED), and inpatient settings, reflecting the economic impact of AH severity and its comorbidities.
Immediate care for alcohol-associated hepatitis (AH) greatly raises health care costs across outpatient, emergency department (ED), and inpatient settings, reflecting the economic impact of AH severity and its comorbidities.
Immediate care for...
05/18/2026
First Report Managed Care
News
Linvoseltamab Demonstrates Improved Efficacy for Patients With TCE RRMM
05/14/2026
Rebecca Amrick
Linvoseltamab outperformed real-world treatment regimens for patients with triple-class exposed (TCE) relapsed or refractory multiple myeloma (RRMM), with higher response rates and more durable outcomes in the LINKER-MM1 trial.
Linvoseltamab outperformed real-world treatment regimens for patients with triple-class exposed (TCE) relapsed or refractory multiple myeloma (RRMM), with higher response rates and more durable outcomes in the LINKER-MM1 trial.
Linvoseltamab outperformed...
05/14/2026
First Report Managed Care
News
IMC Care Matches ICU Outcomes for Hypertensive Emergencies, Study Finds
05/04/2026
Rebecca Amrick
In a recent study, patients with hypertensive emergencies had similar outcomes in intermediate care (IMC) and intensive care unit (ICU) settings, suggesting IMC units may safely reduce ICU utilization without compromising care.
In a recent study, patients with hypertensive emergencies had similar outcomes in intermediate care (IMC) and intensive care unit (ICU) settings, suggesting IMC units may safely reduce ICU utilization without compromising care.
In a recent study, patients with...
05/04/2026
First Report Managed Care
News
Adjuvant Immunotherapy Costs Challenge Lung Cancer Affordability
05/04/2026
Hannah Musick
Adjuvant immunotherapies may improve lung cancer outcomes, but high costs and budget impact concerns highlight the need for biomarker-guided use, value-based pricing, and phased adoption.
Adjuvant immunotherapies may improve lung cancer outcomes, but high costs and budget impact concerns highlight the need for biomarker-guided use, value-based pricing, and phased adoption.
Adjuvant immunotherapies may...
05/04/2026
First Report Managed Care
News
Teclistamab Shows Comparable Efficacy but Lower Costs Than Elranatamab in RRMM Study
05/04/2026
Rebecca Amrick
With similar response rates but consistently lower costs, teclistamab may offer a more economically favorable option than elranatamab for patients with relapsed or refractory multiple myeloma (RRMM), according to a study published in the...
With similar response rates but consistently lower costs, teclistamab may offer a more economically favorable option than elranatamab for patients with relapsed or refractory multiple myeloma (RRMM), according to a study published in the...
With similar response rates but...
05/04/2026
First Report Managed Care
News
Glofitamab Emerges as an Accessible, High-Potential Alternative to CAR T Therapy in DLBCL
04/29/2026
Rebecca Amrick
Dr Tycel Phillips from Blood Cancers Today explains how the bispecific antibody glofitamab may offer a more accessible and potentially curative alternative to chimeric antigen receptor (CAR) T-cell therapy for patients with diffuse large...
Dr Tycel Phillips from Blood Cancers Today explains how the bispecific antibody glofitamab may offer a more accessible and potentially curative alternative to chimeric antigen receptor (CAR) T-cell therapy for patients with diffuse large...
Dr Tycel Phillips from Blood...
04/29/2026
First Report Managed Care
News
Hemodialysis Triggers Wide Epigenetic Changes in Patients With Chronic Kidney Disease
04/27/2026
Rebecca Amrick
A small-scale exploratory study analyzed the impact of hemodialysis on DNA methylation patterns and found inflammation to be linked a system-wide reaction.
A small-scale exploratory study analyzed the impact of hemodialysis on DNA methylation patterns and found inflammation to be linked a system-wide reaction.
A small-scale exploratory study...
04/27/2026
First Report Managed Care

Pipeline Projections

PIPELINE PROJECTIONS
Emerging Therapies Reshaping Atopic Dermatitis Care
03/26/2026
Roy Moore
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore outlines how a rapidly...
03/26/2026
First Report Managed Care
Pipe
Pipeline Projections
Emerging Migraine Treatments Challenge a Mature Market
11/20/2025
Roy Moore
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market...
11/20/2025
First Report Managed Care
Pipeline Projections
Pipeline Projections
Redefining Asthma Management With Emerging Anti-Inflammatories
10/01/2025
Roy Moore
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
Roy Moore, a market access...
10/01/2025
First Report Managed Care
Pipeline Projections
The Shift in MS Care as Biologics and BTK Inhibitors Advance
07/25/2025
Roy Moore
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this edition of Pipeline...
07/25/2025
First Report Managed Care
Pipeline Projections
How Biosimilars Are Shaping RA Treatment and Reimbursement Strategies
04/29/2025
Roy Moore
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
In this episode of Pipeline...
04/29/2025
First Report Managed Care

Behind the Bill

Behind the Bill
HHS Hits Reset on 340B Rebate Model After Court Setbacks
02/11/2026
Juliet Gallagher
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
The US Department of Health and...
02/11/2026
First Report Managed Care
Behind the Bill
Funding Package Extends Medicare Telehealth, Enacts PBM Reforms, and Updates Hospital Oversight
02/05/2026
Juliet Gallagher
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
On February 3, 2026, President...
02/05/2026
First Report Managed Care
Behind the Bill
The Senate’s $3 Trillion Deal. Tax Relief Now, Medicaid Coverage Loss Later?
07/02/2025
Katie Hayes, MJ
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After...
07/02/2025
First Report Managed Care
Behind the Bill
When a Cap Isn’t Just a Cap: How a Provider Tax Proposal Could Reshape Medicaid Financing
06/25/2025
Katie Hayes, MJ
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most...
06/25/2025
First Report Managed Care
Behind the Bill
Rewriting the Safety Net? Inside the Senate’s Changes to Medicaid and the ACA
06/18/2025
Katie Hayes, MJ
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve...
06/18/2025
First Report Managed Care
Behind the Bill
How States Might Respond to the One Big Beautiful Bill Act
06/11/2025
Katie Hayes, MJ
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill...
06/11/2025
First Report Managed Care
Behind the Bill
Is the Affordable Care Act on the Chopping Block? What the One Big Beautiful Bill Act Tells Us.
06/04/2025
Katie Hayes, MJ
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of...
06/04/2025
First Report Managed Care
Behind the Bill
From House to Senate: The Journey of Cutting Medicaid
05/28/2025
Katie Hayes, MJ
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of...
05/28/2025
First Report Managed Care
Behind the Bill
Eligibility, Paperwork, and Penalties: The Not-So-Hidden Costs of Medicaid ‘Reform’
05/21/2025
Katie Hayes, MJ
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week...
05/21/2025
First Report Managed Care
Behind the Bill
A Busy Week in Drug Pricing Policy: Aligning US Drug Prices With Global Standards?
05/14/2025
Katie Hayes, MJ
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for...
05/14/2025
First Report Managed Care

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use